Article (Scientific journals)
Guidelines for the use of epoetin: have quality-of-life benefits been proven?
Bottomley, Andrew; Thomas, Ronald; Van Steen, Kristel et al.
2003In Journal of Clinical Oncology, 21 (11), p. 2223; author reply 2224-5
Peer Reviewed verified by ORBi
 

Files


Full Text
Bottomley_2003_Gidelines for the use of.pdf
Publisher postprint (33.98 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Anemia/drug therapy/etiology; Erythropoietin/therapeutic use; Erythropoietin, Recombinant; Humans; Neoplasms/complications/drug therapy; Quality of Life
Disciplines :
Oncology
Author, co-author :
Bottomley, Andrew
Thomas, Ronald
Van Steen, Kristel  ;  Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique
Flechtner, Henning
de Graeff, Alexander
Language :
English
Title :
Guidelines for the use of epoetin: have quality-of-life benefits been proven?
Publication date :
2003
Journal title :
Journal of Clinical Oncology
ISSN :
0732-183X
eISSN :
1527-7755
Publisher :
American Society of Clinical Oncology, Alexandria, United States - Virginia
Volume :
21
Issue :
11
Pages :
2223; author reply 2224-5
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 22 May 2010

Statistics


Number of views
34 (7 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
3
Scopus citations®
without self-citations
3
OpenCitations
 
3

Bibliography


Similar publications



Contact ORBi